NALCN and non-small cell lung carcinoma: Interestingly, in alimited number of the 11 pairsof tissues, hypermethylation of the NALCN gene promoter was detected in 6 of 9 (66.7%) patients who relapsed, and in none of the two relapse-free NSCLC patients.